<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   &lt;i&gt;Mycoplasma genitalium&lt;/i&gt; infection
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       <i>
        Mycoplasma genitalium
       </i>
       infection
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        <i>
         Mycoplasma genitalium
        </i>
        infection
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David H Martin, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            William M Geisler, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jeanne Marrazzo, MD, MPH, FACP, FIDSA
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Allyson Bloom, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 10, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H11966203">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          Mycoplasma genitalium
         </em>
         is a bacterium that is a common cause of nongonococcal urethritis in males and cervicitis in females. It also may be a cause of pelvic inflammatory disease (PID) in females. It is uncertain whether
         <em>
          M. genitalium
         </em>
         causes proctitis in men who have sex with men (MSM).
        </p>
        <p>
         <em>
          M. genitalium
         </em>
         infection is discussed here. Other causes of urethritis, cervicitis, and PID, are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/86698.html" rel="external">
          "Urethritis in adult males"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5460.html" rel="external">
          "Acute cervicitis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7581.html" rel="external">
          "Pelvic inflammatory disease: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
         Infections caused by other
         <em>
          Mycoplasma
         </em>
         species are also discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/6989.html" rel="external">
          "
          <i>
           Mycoplasma pneumoniae
          </i>
          infection in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6070.html" rel="external">
          "
          <i>
           Mycoplasma pneumoniae
          </i>
          infection in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5508.html" rel="external">
          "
          <i>
           Mycoplasma hominis
          </i>
          and
          <i>
           Ureaplasma
          </i>
          infections"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11966210">
         <span class="h1">
          MICROBIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. genitalium
         </em>
         was first described in 1981 after being isolated from the urethral specimens of two men diagnosed with nongonococcal urethritis [
         <a href="#rid1">
          1
         </a>
         ]. It is a member of the Mycoplasmataceae family and Mollicutes class of bacteria [
         <a href="#rid2">
          2
         </a>
         ]. It lacks a cell wall and is thus not visible following Gram staining. With a genome of only 580 kilobases in size,
         <em>
          M. genitalium
         </em>
         is the smallest known self-replicating bacterium. Its genomic structure is similar to the larger and more well-known pathogen
         <em>
          Mycoplasma pneumoniae
         </em>
         , a cause of atypical bacterial pneumonia [
         <a href="#rid3">
          3
         </a>
         ]. It appears that
         <em>
          M. genitalium
         </em>
         evolved from
         <em>
          M. pneumoniae
         </em>
         by reductive evolution [
         <a href="#rid4">
          4
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6989.html" rel="external">
          "
          <i>
           Mycoplasma pneumoniae
          </i>
          infection in adults"
         </a>
         .)
        </p>
        <p>
         Culture of
         <em>
          M. genitalium
         </em>
         is extremely difficult, as the organism is fastidious and may require one to two months to grow. In vitro growth is enhanced by cocultivation with mammalian cells, but even under the best circumstances, only about 50 percent of samples from infected patients yield positive cultures [
         <a href="#rid5">
          5
         </a>
         ]. Culture is thus unlikely to ever be used for the diagnosis of
         <em>
          M. genitalium
         </em>
         infections.
        </p>
        <p class="headingAnchor" id="H11966217">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is no solid evidence that
         <em>
          M. genitalium
         </em>
         causes clinical disease outside the genitourinary tract [
         <a href="#rid6">
          6-8
         </a>
         ]. Studies in both male and female nonhuman primates, in which genital infection developed following urogenital inoculation of
         <em>
          M. genitalium
         </em>
         , demonstrate its pathogenicity [
         <a href="#rid9">
          9
         </a>
         ]. A specialized terminal tip-like structure allows
         <em>
          M. genitalium
         </em>
         to attach to, adhere to the surface of, and enter cells. [
         <a href="#rid10">
          10
         </a>
         ]. Upon entry into the epithelial cell,
         <em>
          M. genitalium
         </em>
         evades the host immune response through modulation of the immune system, including suppression and stimulation of lymphocytes and upregulation of cytokine expression [
         <a href="#rid11">
          11
         </a>
         ]. The tissue destruction caused by
         <em>
          M. genitalium
         </em>
         is partially due to the secretion of mycoplasmal toxins and harmful metabolites like hydrogen peroxide. However, most of the clinical disease manifestations associated with
         <em>
          M. genitalium
         </em>
         infection are thought to be due to the host's immune response to cell invasion [
         <a href="#rid8">
          8
         </a>
         ]. Most
         <em>
          M. genitalium
         </em>
         infections in females are cleared within six months, but some may persist for approximately one year [
         <a href="#rid12">
          12,13
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11966231">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H23915319">
         <span class="h2">
          Prevalence
         </span>
         <span class="headingEndMark">
          —
         </span>
         Globally, the prevalence estimates of
         <em>
          M. genitalium
         </em>
         range between 1 and 4 percent among males and 1 and 6.4 percent among females [
         <a href="#rid14">
          14-16
         </a>
         ]. In studies from the United States, the prevalence of
         <em>
          M. genitalium
         </em>
         is approximately 1 percent among young adults in the general population, placing it between that of
         <em>
          Neisseria gonorrhoeae
         </em>
         (0.4 percent) and
         <em>
          Chlamydia trachomatis
         </em>
         (2.3 percent) [
         <a href="#rid17">
          17
         </a>
         ]. Higher
         <em>
          M. genitalium
         </em>
         prevalence rates, ranging from 4 to 38 percent, have been reported among sexually transmitted infection (STI) clinic attendees and cohorts with multiple STI risk factors [
         <a href="#rid18">
          18-21
         </a>
         ]. As an example, one study found a prevalence of
         <em>
          M. genitalium
         </em>
         of 7.7 percent in females attending a Seattle STI clinic, compared with a prevalence of 5.8 percent for
         <em>
          C. trachomatis
         </em>
         and 2.4 percent for
         <em>
          N. gonorrhoeae
         </em>
         [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H23914721">
         <span class="h2">
          Risk factors for infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Risk factors associated with
         <em>
          M. genitalium
         </em>
         infection appear to be similar to those associated with
         <em>
          C. trachomatis
         </em>
         infection. In studies from the United States and Europe, these include young age (eg, &lt;20 to 22 years old), smoking, recent sexual intercourse, and an increasing number of sexual partners [
         <a href="#rid17">
          17,22-28
         </a>
         ].
        </p>
        <p>
         In one study, having had ≥2 sexual partners over the previous year and bacterial vaginosis were independently associated with
         <em>
          M. genitalium
         </em>
         colonization [
         <a href="#rid29">
          29
         </a>
         ]. In a study of female sex workers in Uganda, the prevalence of
         <em>
          M. genitalium
         </em>
         was higher in HIV-positive women than in HIV-negative women [
         <a href="#rid30">
          30
         </a>
         ]. (See
         <a class="local">
          'Coinfection'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H23915130">
         <span class="h3">
          Evidence of sexual transmissibility
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sexual transmissibility of
         <em>
          M. genitalium
         </em>
         is supported by both clinical and molecular epidemiologic evidence. As above,
         <em>
          M. genitalium
         </em>
         is detected more frequently among sexually experienced than sexually naive adolescents, and infection is associated with an increasing number of sexual partners [
         <a href="#rid17">
          17,23,26,27,29
         </a>
         ]. Additionally, the organism is more likely to be detected in the sexual partners of
         <em>
          M. genitalium
         </em>
         -positive compared with -negative individuals [
         <a href="#rid26">
          26,31-34
         </a>
         ]. In one meta-analysis of 10 studies evaluating infections among sexual partners, 39 to 50 percent of male partners of infected females and 40 to 50 percent of female partners of infected males were also infected [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
         Furthermore, in DNA-typing studies, sexual partners who were concurrently infected with
         <em>
          M. genitalium
         </em>
         often harbored genomically identical bacterial strains [
         <a href="#rid36">
          36-38
         </a>
         ]. In one study comparing the
         <em>
          M. genitalium
         </em>
         genotype profiles of 31 concurrently infected couples and 74 unrelated pairs of individuals, a concordance rate of 87.1 percent was observed for the couples compared with only 5.4 percent for the unrelated pairs of individuals [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H23915541">
         <span class="h2">
          Coinfection
         </span>
        </p>
        <p class="headingAnchor" id="H1446970183">
         <span class="h3">
          Bacterial and parasitic sexually transmitted infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Coinfections with
         <em>
          M. genitalium
         </em>
         and other bacterial and parasitic sexually transmitted infections (STIs) frequently have been reported among high-risk males and females [
         <a href="#rid25">
          25,26,30,39-42
         </a>
         ]. As an example, in a study of men with urethritis, 35 percent of those with
         <em>
          C. trachomatis
         </em>
         , 14 percent of those with
         <em>
          N. gonorrhoeae
         </em>
         , and 19 percent with both infections were also infected with
         <em>
          M. genitalium
         </em>
         [
         <a href="#rid41">
          41
         </a>
         ].
         <em>
          C. trachomatis
         </em>
         is the most commonly reported coinfecting organism in patients with
         <em>
          M. genitalium
         </em>
         infection.
         <em>
          Trichomonas vaginalis
         </em>
         is also a commonly reported coinfection in females with
         <em>
          M. genitalium
         </em>
         infection [
         <a href="#rid20">
          20
         </a>
         ]. The high frequency of STI coinfections in
         <em>
          M. genitalium
         </em>
         -positive individuals is not surprising given the shared epidemiologic characteristics among these organisms. It has also created challenges in discerning the independent role of
         <em>
          M. genitalium
         </em>
         in the pathogenesis of urogenital disease.
        </p>
        <p class="headingAnchor" id="H767204190">
         <span class="h3">
          HIV
         </span>
         <span class="headingEndMark">
          —
         </span>
         Numerous observational studies have suggested an association between
         <em>
          M. genitalium
         </em>
         and HIV infection [
         <a href="#rid30">
          30,43-49
         </a>
         ]. In a nested case-control study of high-risk women in Kampala, Uganda, there was an association between HIV acquisition and
         <em>
          M. genitalium
         </em>
         detection three months prior to the HIV-positive result [
         <a href="#rid50">
          50
         </a>
         ]. Similarly, in another study,
         <em>
          M. genitalium
         </em>
         was detected more frequently in the 183 females who subsequently became infected with HIV compared with the 337 matched controls (14.8 versus 6.5 percent) [
         <a href="#rid48">
          48
         </a>
         ]. The presence of
         <em>
          M. genitalium
         </em>
         was independently associated with genital HIV RNA detection in a longitudinal cohort study of 131 Zimbabwean women with recent HIV seroconversion [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
         These findings are supported by in vitro studies, in which
         <em>
          M. genitalium
         </em>
         reduced the integrity of the endocervical epithelial barrier and activated HIV target cells, thus providing a possible mechanism whereby this organism enhances HIV transmissibility [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11966282">
         <span class="h1">
          ASSOCIATED CLINICAL SYNDROMES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Epidemiologic studies have suggested a strong etiologic link between
         <em>
          M. genitalium
         </em>
         infection and urethritis in males and a moderate etiologic link with cervicitis. It may be a cause of pelvic inflammatory disease (PID) in females. Although rectal
         <em>
          M. genitalium
         </em>
         infection rates are high among men who have sex with men (MSM), it is uncertain whether
         <em>
          M. genitalium
         </em>
         causes proctitis. Because of the difficulties with isolating this pathogen in culture, knowledge about the clinical manifestations of
         <em>
          M. genitalium
         </em>
         infection is based on nucleic acid amplification tests (NAATs).
        </p>
        <p class="headingAnchor" id="H11966290">
         <span class="h2">
          Nongonococcal urethritis in men
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infection with
         <em>
          M. genitalium
         </em>
         has been strongly associated with acute nongonococcal urethritis (NGU). When present, the typical symptoms of urethritis caused by
         <em>
          M. genitalium
         </em>
         are similar to those reported in urethritis from other causes and include dysuria, urethral pruritus, and purulent or mucopurulent urethral discharge [
         <a href="#rid53">
          53
         </a>
         ]. NGU cases are frequently asymptomatic [
         <a href="#rid28">
          28,31,54,55
         </a>
         ]. However, NGU due to
         <em>
          M. genitalium
         </em>
         infection appears to be symptomatic more often than with
         <em>
          C. trachomatis
         </em>
         infection. In one study, 70 percent of
         <em>
          M. genitalium
         </em>
         -infected males reported symptoms compared with only 40 percent of
         <em>
          C. trachomatis
         </em>
         -infected males [
         <a href="#rid31">
          31
         </a>
         ]. On examination, urethral discharge is often present. However, as with chlamydial urethral infections, the discharge may not be grossly evident, and urethral stripping, or milking, may be necessary for detection [
         <a href="#rid41">
          41
         </a>
         ].
         <em>
          M. genitalium
         </em>
         infection also may be associated with balanitis (ie, inflammation of the glans penis) and posthitis (ie, inflammation of the foreskin) [
         <a href="#rid56">
          56
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/86698.html" rel="external">
          "Urethritis in adult males", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
         In a meta-analysis of 19 observational studies that evaluated
         <em>
          M. genitalium
         </em>
         infection using polymerase chain reaction (PCR) assays, 436 of 2069 patients with NGU (21.1 percent) had
         <em>
          M. genitalium
         </em>
         detected compared with 121 of 1810 controls (6.7 percent, pooled odds ratio [OR] 3.8, 95% CI 3.0-4.9) [
         <a href="#rid8">
          8,57
         </a>
         ]. Subsequent systematic reviews of additional observational studies have supported this association, which is particularly strong in cases of nonchlamydial NGU (NCNGU) [
         <a href="#rid10">
          10,58
         </a>
         ].
        </p>
        <p>
         <em>
          M. genitalium
         </em>
         infection is estimated to account for 15 to 20 percent of NGU cases reported per year among males in the United States [
         <a href="#rid53">
          53
         </a>
         ]. Among males with NCNGU,
         <em>
          M. genitalium
         </em>
         has been detected in 18 to 46 percent of cases [
         <a href="#rid59">
          59
         </a>
         ]. Similarly,
         <em>
          M. genitalium
         </em>
         detection was frequent in males with persistent or recurrent urethritis following empiric therapy, particularly when
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         was used initially for treatment instead of
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         [
         <a href="#rid10">
          10,58,60
         </a>
         ]. (See
         <a class="local">
          'Treatment'
         </a>
         below.)
        </p>
        <p>
         <em>
          M. genitalium
         </em>
         may also be associated with urethritis in females, although data are too limited to draw clear conclusions [
         <a href="#rid10">
          10,58
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11966297">
         <span class="h2">
          Cervicitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. genitalium
         </em>
         is a recognized sexually transmitted infection (STI) in females. Overall, cumulative evidence suggests an association between
         <em>
          M. genitalium
         </em>
         and cervicitis, although some results are conflicting [
         <a href="#rid12">
          12,46,61,62
         </a>
         ]. Females with cervicitis due to
         <em>
          M. genitalium
         </em>
         frequently have no symptoms at all, similar to those with cervicitis due to
         <em>
          C. trachomatis
         </em>
         [
         <a href="#rid25">
          25,26,32,55
         </a>
         ]. When present, symptoms associated with
         <em>
          M. genitalium
         </em>
         infection are usually nonspecific, with the most commonly reported symptom being vaginal discharge [
         <a href="#rid26">
          26,63,64
         </a>
         ]. Other symptoms include vaginal itching, dysuria, and pelvic discomfort [
         <a href="#rid25">
          25
         </a>
         ]. Clinical findings associated with
         <em>
          M. genitalium
         </em>
         cervicitis include the purulent or mucopurulent cervical discharge and cervical friability. If specifically sought, elevated numbers of polymorphonuclear leukocyte cells on vaginal wet smear or cervical fluid Gram stain may be found [
         <a href="#rid32">
          32,55,65-67
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5460.html" rel="external">
          "Acute cervicitis", section on 'Clinical presentation'
         </a>
         .)
        </p>
        <p>
         In a meta-analysis of 20 studies, most of which employed in-house PCR testing to identify
         <em>
          M. genitalium
         </em>
         , detection of the organism was associated with cervicitis (OR 1.66, 95% CI 1.35-2.04) [
         <a href="#rid68">
          68
         </a>
         ]. In one study from the meta-analysis that included 719 females who had cervical specimens obtained at an STI clinic, those with
         <em>
          M. genitalium
         </em>
         detected by PCR were more likely to have mucopurulent cervicitis (defined by the presence of either visible purulent discharge or ≥30 polymorphonuclear cells [PMNs] per high power field on Gram stain of cervical smear) compared with those without detectable
         <em>
          M. genitalium
         </em>
         (48 versus 28.6 percent) [
         <a href="#rid23">
          23
         </a>
         ]. After controlling for infections with other STIs that cause cervicitis, the study observed a threefold increased risk of mucopurulent cervicitis in females infected with
         <em>
          M. genitalium
         </em>
         .
        </p>
        <p>
         In contrast, some other studies of high-risk female populations have failed to demonstrate an association between
         <em>
          M. genitalium
         </em>
         detection and cervicitis, despite high
         <em>
          M. genitalium
         </em>
         detection rates [
         <a href="#rid25">
          25,39
         </a>
         ]. As an example, in a study of 331 adolescent females presenting with genitourinary symptoms or STI risk factors to an urban health center in the United States,
         <em>
          M. genitalium
         </em>
         was detected in 22.4 percent but was not associated with vaginal symptoms or signs (purulent cervical discharge or cervical friability) of cervicitis [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
         Inconsistent associations between
         <em>
          M. genitalium
         </em>
         and cervicitis are likely due to the lack of a standard definition of cervicitis. Most, but not all, studies that defined cervicitis as ≥30 PMNs per high power field in the cervical smear observed higher rates of
         <em>
          M. genitalium
         </em>
         in females with cervicitis than in those without [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11966304">
         <span class="h2">
          Pelvic inflammatory disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. genitalium
         </em>
         can ascend from the lower to upper genital tract after sexual transmission [
         <a href="#rid11">
          11
         </a>
         ], and several studies have reported associations between detection of the organism and clinical signs or symptoms of pelvic inflammatory disease (PID) [
         <a href="#rid29">
          29,61,69-72
         </a>
         ]. Clinical manifestations of
         <em>
          M. genitalium
         </em>
         -associated PID include mild to severe pelvic pain, abdominal pain, abnormal vaginal discharge, and/or bleeding, similar to PID due to
         <em>
          C. trachomatis
         </em>
         . In a study of females with clinically suspected PID, females with
         <em>
          M. genitalium
         </em>
         -associated PID were less likely to have elevated systemic inflammatory markers or elevated leukocyte count and were less likely to present with mucopurulent cervicitis or report high pain scores when compared with females with
         <em>
          N. gonorrhoeae
         </em>
         infection [
         <a href="#rid73">
          73
         </a>
         ]. Females with PID due to
         <em>
          M. genitalium
         </em>
         and
         <em>
          C. trachomatis
         </em>
         reported similar symptoms. (See
         <a class="medical medical_review" href="/z/d/html/7581.html" rel="external">
          "Pelvic inflammatory disease: Clinical manifestations and diagnosis", section on 'Clinical features'
         </a>
         .)
        </p>
        <p>
         Overall, the data suggest a possible association and causative role between
         <em>
          M. genitalium
         </em>
         and PID, although the risk of PID with
         <em>
          M. genitalium
         </em>
         infection does not appear as high as that with
         <em>
          C. trachomatis
         </em>
         . In a meta-analysis of 10 studies, the pooled OR for PID among females with
         <em>
          M. genitalium
         </em>
         infection was 2.14 (95% CI 1.31-3.49) [
         <a href="#rid68">
          68
         </a>
         ]. The following studies illustrate the range of findings:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a study of 50 females with nongonococcal, nonchlamydial PID,
         <em>
          M. genitalium
         </em>
         was present in 14 percent of endometrial biopsies [
         <a href="#rid69">
          69
         </a>
         ]. Similarly, in a study of females presenting to a Kenyan STI clinic with pelvic pain,
         <em>
          M. genitalium
         </em>
         was detected from cervical and/or endometrial samples more frequently in the 58 females with histologically diagnosed endometritis than in the 57 without (16 versus 2 percent) [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a prospective study of 2246 sexually active English female college students, the baseline prevalence of
         <em>
          M. genitalium
         </em>
         in self-collected vaginal specimens was low (3.3 percent), and there was a nonsignificant increase in incidence of PID over a 12-month period among females with detectable
         <em>
          M. genitalium
         </em>
         compared with those in whom it was not detected (risk ratio 2.35, 95% CI 0.74-7.46) [
         <a href="#rid29">
          29
         </a>
         ]. Subsequent analysis suggested that an estimated 4.9 percent of females with
         <em>
          M. genitalium
         </em>
         infection developed PID compared with 14.4 percent of those with
         <em>
          C. trachomatis
         </em>
         infection [
         <a href="#rid74">
          74
         </a>
         ]. Based on the risk of PID suggested by these data, it would be difficult to determine if screening asymptomatic females for
         <em>
          M. genitalium
         </em>
         could prevent PID.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a smaller prospective study of females undergoing termination of pregnancy in Sweden, the incidence of postprocedure PID was higher among the 49 females who tested positive for
         <em>
          M. genitalium
         </em>
         at baseline than among the 168 STI-negative controls matched for age and procedure (12.2 versus 2.4 percent) [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Although PID in general is associated with infertility, it is unclear whether
         <em>
          M. genitalium
         </em>
         leads to tubal factor infertility, with different studies showing conflicting results [
         <a href="#rid10">
          10
         </a>
         ]. A meta-analysis of observational studies suggested that
         <em>
          M. genitalium
         </em>
         is also associated with adverse pregnancy outcomes, such as preterm birth and spontaneous abortion [
         <a href="#rid68">
          68
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1761566620">
         <span class="h2">
          Proctitis in men who have sex with men
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is uncertain whether
         <em>
          M. genitalium
         </em>
         is a cause of proctitis in men who have sex with men (MSM). In one study of 166 MSM with proctitis in Australia,
         <em>
          M. genitalium
         </em>
         was identified in 17 percent as a single pathogen and in 22 percent as a copathogen [
         <a href="#rid75">
          75
         </a>
         ]. However, in another study of over 1000 MSM in Australia,
         <em>
          M. genitalium
         </em>
         was isolated from the rectum at comparable rates among asymptomatic men and those with symptomatic proctitis [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p>
         The clinical features of proctitis are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3730.html" rel="external">
          "Evaluation of anorectal symptoms in men who have sex with men", section on 'Proctitis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3420189635">
         <span class="h2">
          Other
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. genitalium
         </em>
         is primarily associated with anogenital infection and is not thought to have propensity to spread systemically. One case report suggested
         <em>
          M. genitalium
         </em>
         as the cause of prosthetic valve endocarditis, based on molecular testing of the explanted valve, in an individual who presented four months following a gynecologic procedure [
         <a href="#rid77">
          77
         </a>
         ]. Additional studies are necessary to understand whether and how
         <em>
          M. genitalium
         </em>
         can cause disease outside the anogenital tract.
        </p>
        <p class="headingAnchor" id="H99103250">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other sexually transmitted pathogens, especially
         <em>
          C. trachomatis
         </em>
         and
         <em>
          N. gonorrhoeae
         </em>
         , can cause similar disease presentations. Additionally, nonsexually transmitted infections and noninfectious conditions can occasionally cause signs and symptoms comparable to those seen in sexually transmitted infectious syndromes.
        </p>
        <p>
         The differential diagnoses of the specific syndromes associated with
         <em>
          M. genitalium
         </em>
         infection are discussed in detail elsewhere:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/86698.html" rel="external">
          "Urethritis in adult males", section on 'Nongonococcal urethritis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/86698.html" rel="external">
          "Urethritis in adult males", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5460.html" rel="external">
          "Acute cervicitis", section on 'Epidemiology and etiology'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7581.html" rel="external">
          "Pelvic inflammatory disease: Clinical manifestations and diagnosis", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3730.html" rel="external">
          "Evaluation of anorectal symptoms in men who have sex with men", section on 'Proctitis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11966311">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of
         <em>
          M. genitalium
         </em>
         infection can be made through detection of the organism using polymerase chain reaction (PCR) or other, more recently developed nucleic acid amplification tests (NAATs), if available. The preferred specimens are a first-catch urine sample in males and a vaginal swab in females [
         <a href="#rid24">
          24,39,78-82
         </a>
         ].
        </p>
        <p>
         The diagnoses of the clinical syndromes associated with
         <em>
          M. genitalium
         </em>
         are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/86698.html" rel="external">
          "Urethritis in adult males", section on 'Diagnosis'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7581.html" rel="external">
          "Pelvic inflammatory disease: Clinical manifestations and diagnosis", section on 'Evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5460.html" rel="external">
          "Acute cervicitis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4071438346">
         <span class="h2">
          Whom to test
         </span>
         <span class="headingEndMark">
          —
         </span>
         The optimal role for
         <em>
          M. genitalium
         </em>
         testing is uncertain.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Our approach
         </strong>
         – We favor testing for
         <em>
          M. genitalium
         </em>
         in the following individuals:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Symptomatic patients with urethritis, cervicitis, and pelvic inflammatory disease (PID), including those with persistent symptoms after empiric treatment.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sex partners of the above patients, if they are seen before laboratory results for the index case are available; if the index case laboratory results are available when the partner is seen, we test only partners of those who have tested positive for
         <em>
          M. genitalium.
         </em>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Support for this approach comes from a large study from a single center that transitioned its approach to nongonococcal urethritis from testing only for
         <em>
          C. trachomatis
         </em>
         and
         <em>
          N. gonorrhoeae
         </em>
         and empirically treating with
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         to testing also for
         <em>
          M. genitalium
         </em>
         and empirically treating with
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (followed by
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         if positive for
         <em>
          M. genitalium
         </em>
         ) [
         <a href="#rid83">
          83
         </a>
         ]. The latter approach was associated with a lower rate of visits for persistent urethritis (3 versus 8 percent); following the transition,
         <em>
          M. genitalium
         </em>
         was detected at 18 percent of visits.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Guideline recommendations
         </strong>
         – This approach is consistent with guidelines from the United Kingdom [
         <a href="#rid84">
          84
         </a>
         ], Europe [
         <a href="#rid85">
          85
         </a>
         ], and Australia [
         <a href="#rid86">
          86
         </a>
         ], although in some of those guidelines, the strength of the recommendation is lower for testing females with cervicitis. (See
         <a class="local">
          'Cervicitis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Guidelines from the United States Centers for Disease Control and Prevention (CDC) recommend testing for
         <em>
          M. genitalium
         </em>
         only in patients with persistent symptoms of urethritis and cervicitis following completion of standard syndromic treatment [
         <a href="#rid53">
          53
         </a>
         ]. These guidelines also state that
         <em>
          M. genitalium
         </em>
         testing can be considered in the initial evaluation of cervicitis and among females with PID.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          No role for routine screening
         </strong>
         – Routine screening for
         <em>
          M. genitalium
         </em>
         in asymptomatic individuals is not recommended. Detection and treatment of infections due to
         <em>
          M. genitalium
         </em>
         in high-risk asymptomatic persons have not yet been demonstrated to
         <em>
         </em>
         prevent PID, infertility, adverse pregnancy outcomes, and/or HIV transmission in either males or females [
         <a href="#rid87">
          87
         </a>
         ]. Further research is needed to address these important questions.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2399385109">
         <span class="h2">
          Microbiologic testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         The tests of choice for detection of
         <em>
          M. genitalium
         </em>
         in clinical specimens are NAATs. In the United States, several NAATs have been cleared by the US Food and Drug Administration (FDA) for this purpose [
         <a href="#rid88">
          88
         </a>
         ]. Other assays are available in other parts of the world [
         <a href="#rid89">
          89,90
         </a>
         ]. If NAAT-based assays for simultaneous detection of
         <em>
          M. genitalium
         </em>
         and macrolide-resistance genes are available, as in some countries (eg, Europe, Asia, and Australia, but not the United States), these should be used. (See
         <a class="local">
          'Antimicrobial susceptibility'
         </a>
         below.)
        </p>
        <p>
         Specimens that can be tested with these assays include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For males: Urethral swab, urethral meatus swab (either clinician- or self-collected), and first-catch urine; these are equally sensitive.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For females: Vaginal swab (either clinician- or self-collected), endocervical swab, and first-catch urine; the vaginal swab is the optimal specimen because it has higher sensitivity compared with other specimen types.
        </p>
        <p>
        </p>
        <p>
         The same specimen can be used to test for
         <em>
          C. trachomatis
         </em>
         ,
         <em>
          N. gonorrhoeae,
         </em>
         and
         <em>
          T. vaginalis.
         </em>
        </p>
        <p>
         Urine specimens should be a first-catch urine (ie, the first 10 mL of the initial stream of urine collected without precleaning of the genital areas). Ideally, the patient should not have voided for at least one hour prior to specimen collection.
        </p>
        <p>
         The sensitivity of the
         <em>
          M. genitalium
         </em>
         assays that are FDA cleared for use in the United States ranges from 78 to 100 percent; the specificity ranges from 96 to 99 percent [
         <a href="#rid91">
          91-93
         </a>
         ].
        </p>
        <p>
         Traditional microbiologic methods of bacterial diagnosis are not clinically useful in the diagnosis of
         <em>
          M. genitalium
         </em>
         infections. The lack of a cell wall prevents
         <em>
          M. genitalium
         </em>
         identification by routine Gram staining, and its fastidious growth requirements make in vitro cultivation for diagnosis nearly impossible [
         <a href="#rid6">
          6,94,95
         </a>
         ]. Additionally, there are no standardized serologic tests for
         <em>
          M. genitalium
         </em>
         [
         <a href="#rid96">
          96
         </a>
         ]. (See
         <a class="local">
          'Microbiology'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H11966325">
         <span class="h1">
          TREATMENT
         </span>
        </p>
        <p class="headingAnchor" id="H11854426">
         <span class="h2">
          Antimicrobial susceptibility
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. genitalium
         </em>
         has relatively limited susceptibility to antibiotic agents. The main active agents are
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         and certain fluoroquinolones, although resistance is an issue for each to varying degrees, as discussed below. As a class, mycoplasmas are largely susceptible to tetracyclines, but
         <em>
          M. genitalium
         </em>
         is an exception to this generalization [
         <a href="#rid10">
          10
         </a>
         ]. Although the organism appears susceptible to the tetracyclines in vitro, microbiologic treatment failures to
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         range from 60 to 70 percent [
         <a href="#rid58">
          58
         </a>
         ]. The lack of a cell wall renders mycoplasmas, including
         <em>
          M. genitalium
         </em>
         , resistant to classes of antibiotics that target cell wall synthesis, such as penicillins and other beta-lactams. It is important to recognize that the in vitro susceptibility studies with this organism are extremely limited, as relatively few cultivated strains are available for study.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Azithromycin
         </strong>
         –
         <em>
          M. genitalium
         </em>
         is inherently susceptible to
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         , but resistance has been increasing globally. A systematic review of 57 studies evaluating the frequency of macrolide-resistance-associated mutations in
         <em>
          M. genitalium
         </em>
         isolates estimated that the prevalence increased from 10 percent in 2010 to 51 percent in 2016 to 2017 [
         <a href="#rid97">
          97
         </a>
         ]. Resistance was greater in the Western Pacific and Americas compared with Europe. Macrolide resistance is mediated by mutations in the 23S ribosomal RNA gene that develop following antibiotic exposure, suggesting antibiotic-induced resistance. Almost all strains tested following azithromycin treatment failure have macrolide-resistance mutations [
         <a href="#rid98">
          98,99
         </a>
         ]. In small studies, the proportion of isolates harboring these mutations has ranged from 14 to 80 percent, and this appears to be increasing [
         <a href="#rid100">
          100-104
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fluoroquinolones
         </strong>
         – Among the fluoroquinolones,
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         has been used most commonly for
         <em>
          M. genitalium
         </em>
         and has been reported in most series to be ≥90 percent effective [
         <a href="#rid105">
          105
         </a>
         ]. Sitafloxacin appears to be equally effective and is only available outside the United States. However, reports of mutations in
         <em>
          M. genitalium
         </em>
         genes parC and gyrA, which are associated with fluoroquinolone resistance, have emerged [
         <a href="#rid102">
          102,106,107
         </a>
         ]. In a systematic review of 25 studies, fluoroquinolone-resistance-associated mutations were reported in 7.7 percent of
         <em>
          M. genitalium
         </em>
         isolates globally [
         <a href="#rid97">
          97
         </a>
         ]. The presence of such mutations has been associated with fluoroquinolone treatment failure [
         <a href="#rid106">
          106,108
         </a>
         ]. There is some evidence that fluoroquinolone treatment failures may be increasing, but given the use of different drugs worldwide, the extent of this problem is unclear [
         <a href="#rid105">
          105
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         In the United States, there are no commercially available antibiotic resistance tests for
         <em>
          M. genitalium
         </em>
         . Nucleic acid amplification tests (NAATs) that are able to detect the organism and macrolide resistance mutations at the same time are available in many parts of the world and will likely be available in the future in the United States [
         <a href="#rid109">
          109
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1297481">
         <span class="h2">
          Empiric syndromic therapy and M. genitalium
         </span>
        </p>
        <p class="headingAnchor" id="H2231493754">
         <span class="h3">
          Cure rates with initial syndromic treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical syndromes with which
         <em>
          M. genitalium
         </em>
         is associated, nongonococcal urethritis, cervicitis, and pelvic inflammatory disease (PID), are typically treated empirically, prior to knowledge of the specific causative pathogen. Empiric treatment of these syndromes includes coverage of
         <em>
          C. trachomatis
         </em>
         , generally with multi-dose
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         or, as an alternative,
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         (usually as a single 1 g dose). Details of the empiric treatment regimens are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/86698.html" rel="external">
          "Urethritis in adult males", section on 'Initial therapy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5460.html" rel="external">
          "Acute cervicitis", section on 'No identifiable pathogen'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7585.html" rel="external">
          "Pelvic inflammatory disease: Treatment in adults and adolescents", section on 'Antibiotic selection'
         </a>
         .)
        </p>
        <p>
         Although these regimens are effective for
         <em>
          C. trachomatis
         </em>
         , they are associated with suboptimal microbiologic cure rates for
         <em>
          M. genitalium
         </em>
         . A seven-day course of
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         substantially reduces organism load in most cases of
         <em>
          M. genitalium
         </em>
         urethritis, but it results in microbiologic cure in only 30 to 40 percent [
         <a href="#rid58">
          58,110
         </a>
         ]. Similarly, because of emerging resistance to
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         , pooled microbiologic cure rates with a single 1 g dose of azithromycin were lower in studies published after 2009 compared with those published earlier (67 versus 85 percent) [
         <a href="#rid111">
          111
         </a>
         ]; the single 1 g dose additionally contributes to the emergence of azithromycin-resistant variants.
        </p>
        <p>
         Thus, it is important to recognize that
         <em>
          M. genitalium
         </em>
         is an important cause of clinical treatment failures following initial empiric treatment of sexually transmitted infection (STI) syndromes (especially for nongonococcal urethritis and probably cervicitis) [
         <a href="#rid112">
          112
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1775902297">
         <span class="h3">
          Empiric M. genitalium therapy for selected syndromic treatment failures
         </span>
         <span class="headingEndMark">
          —
         </span>
         The possibility of
         <em>
          M. genitalium
         </em>
         should be considered in all patients with persistent urethritis, cervicitis, or PID despite initial empiric syndromic therapy. Many of these patients would not have been tested for
         <em>
          M. genitalium
         </em>
         at the time of initial presentation. In such cases, we agree with Centers for Disease Control and Prevention (CDC) recommendations to test for
         <em>
          M. genitalium
         </em>
         . If available, a test that also detects resistance should be performed. While awaiting testing results or if testing is unavailable, decisions on empiric
         <em>
          M. genitalium
         </em>
         therapy depend on the clinical presentation:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Because
         <em>
          M. genitalium
         </em>
         is a common cause of persistent urethritis and cervicitis, we suggest empiric treatment for
         <em>
          M. genitalium
         </em>
         in patients with these clinical syndromes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Whether
         <em>
          M. genitalium
         </em>
         contributes to persistent PID is uncertain, and therefore we only treat patients with persistent PID for
         <em>
          M. genitalium
         </em>
         if they test positive for the pathogen.
        </p>
        <p>
        </p>
        <p>
         Regimen selection for empiric or directed therapy of
         <em>
          M. genitalium
         </em>
         is detailed below.
        </p>
        <p class="headingAnchor" id="H3990342198">
         <span class="h2">
          Regimen selection for M. genitalium
         </span>
        </p>
        <p class="headingAnchor" id="H3331541337">
         <span class="h3">
          Nonpregnant individuals
         </span>
         <span class="headingEndMark">
          —
         </span>
         Decisions on antibiotic selection for
         <em>
          M. genitalium
         </em>
         are usually made without knowledge of the isolate’s susceptibility profile because the availability of resistance testing is limited. In such cases, we favor a moxifloxacin-based regimen, as detailed below, and reserve an azithromycin-based regimen for those who cannot use
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         (due to intolerance or allergy) because of the high prevalence of macrolide-resistant
         <em>
          M. genitalium
         </em>
         . If testing for macrolide resistance-associated mutations was performed, that result can inform antibiotic selection.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preferred regimen (if resistance is unknown)
         </strong>
         – For empiric or directed therapy of
         <em>
          M. genitalium
         </em>
         , we suggest
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (100 mg twice daily for seven days) followed by
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         (400 mg once daily for seven days) to maximize both clinical and microbiologic cure [
         <a href="#rid53">
          53
         </a>
         ]. If the patient has already completed a seven-day course of doxycycline (eg, for initial syndromic therapy) within the past week, it does not have to be repeated, and moxifloxacin can be given alone. In some countries outside the United States, sitafloxacin is used as the primary fluoroquinolone for
         <em>
          M. genitalium
         </em>
         instead of moxifloxacin [
         <a href="#rid104">
          104
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Multiple observational studies have reported high clinical and microbiological cure rates with
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         [
         <a href="#rid58">
          58,99,105,113
         </a>
         ]. A meta-analysis of 17 observational studies evaluating moxifloxacin for
         <em>
          M. genitalium
         </em>
         infections reported a pooled microbiologic cure rate of 96 percent (95% CI 90 to 99 percent) [
         <a href="#rid105">
          105
         </a>
         ]. In one of those studies, 32 males and females with persistent
         <em>
          M. genitalium
         </em>
         after initial therapy with
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         were treated with moxifloxacin (400 mg orally for seven days), and all of the 23 patients who returned for follow-up had microbiologic cure [
         <a href="#rid113">
          113
         </a>
         ]. Nevertheless, reports of mutations in
         <em>
          M. genitalium
         </em>
         associated with fluoroquinolone resistance and treatment failure have also emerged. In an Australian study of 60 individuals with documented
         <em>
          M. genitalium
         </em>
         who failed initial treatment with azithromycin, 53 (88 percent) were cured with moxifloxacin, and all those who failed moxifloxacin had baseline fluoroquinolone-resistance mutations in pretreatment samples [
         <a href="#rid99">
          99
         </a>
         ]. Use of fluoroquinolones may also be limited by rare but severe associated adverse events, including Achilles tendinitis and rupture, peripheral neuropathy, central nervous system disease, and, in older patients and those with vascular disease, aortic aneurysm rupture. (See
         <a class="local">
          'Antimicrobial susceptibility'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/490.html" rel="external">
          "Fluoroquinolones", section on 'Adverse effects'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         usually does not result in microbiologic cure of
         <em>
          M. genitalium
         </em>
         , it reduces bacterial load in most patients. Lowering the level of organism with doxycycline pretreatment is hypothesized to prevent the emergence of fluoroquinolone resistance and increase microbiologic cure with subsequent fluoroquinolone treatment. Sequential treatment with doxycycline followed by
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         is associated with microbiologic and clinical cure rates &gt;90 percent for
         <em>
          M. genitalium
         </em>
         infections [
         <a href="#rid110">
          110,114
         </a>
         ]. Clinical evidence to suggest that this dual therapy approach is better than moxifloxacin alone is lacking; nevertheless, we favor this approach given the concern for increasing antibiotic resistance in the setting of few therapeutic options.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Alternative regimen
         </strong>
         <strong>
          (if resistance is unknown)
         </strong>
         – For empiric or directed therapy of
         <em>
          M. genitalium
         </em>
         in patients who cannot use
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         (eg, because of intolerance or contraindications to fluoroquinolones), we suggest
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (100 mg twice daily for seven days) followed by high-dose
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         (1 g once followed by 500 mg daily the next three days). If the patient has already completed a seven-day course of doxycycline (eg, for initial syndromic therapy) within the past week, it does not have to be repeated, and high-dose azithromycin can be given alone.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The prevalence of macrolide resistance in
         <em>
          M. genitalium
         </em>
         limits the utility of azithromycin-based regimens. Microbiologic cure rates are generally low in the setting of macrolide-resistance mutations, even if high doses are used [
         <a href="#rid104">
          104,110,115
         </a>
         ]. However, azithromycin-based regimens can be associated with clinical cure rates of 65 to 75 percent despite macrolide resistance [
         <a href="#rid115">
          115
         </a>
         ]. The high dose is also associated with a low rate of emergent macrolide resistance [
         <a href="#rid104">
          104,110
         </a>
         ]; with lower
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         doses, the associated rate of emergent macrolide resistance is approximately 10 percent [
         <a href="#rid99">
          99
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         As above, the rationale for using
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         prior to
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         is to reduce bacterial load. Sequential treatment with doxycycline followed by high-dose azithromycin is associated with microbiologic and clinical cure rates &gt;90 percent for macrolide-susceptible
         <em>
          M. genitalium
         </em>
         infections [
         <a href="#rid110">
          110,114
         </a>
         ];
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          If resistance testing can be performed
         </strong>
         – If resistance testing is available, the presence of macrolide resistance-associated gene mutations can inform antibiotic selection:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If an isolate has macrolide resistance, we suggest
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (100 mg twice daily for seven days) followed by
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         (400 mg once daily for seven days).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If an isolate does not have macrolide resistance, we suggest
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (100 mg twice daily for seven days) followed by high-dose
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         (1 g once followed by 500 mg daily for the next three days).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In either case, if the patient has already completed a seven-day course of
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (eg, for initial syndromic therapy) within the past week, it does not have to be repeated prior to the
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         or
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         doses.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         This resistance-guided strategy has been associated with overall microbiologic success rates greater than 90 percent while minimizing toxicity of fluoroquinolones [
         <a href="#rid110">
          110,114
         </a>
         ]. However, such tests are not widely available in the United States. Once tests that can simultaneously detect
         <em>
          M. genitalium
         </em>
         and macrolide resistance-associated gene mutations become more widely available, therapeutic decision-making will become less complex.
        </p>
        <p>
        </p>
        <p>
         This approach to therapy is consistent with recommendations from the CDC in the United States [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2338026846">
         <span class="h3">
          Pregnant individuals
         </span>
         <span class="headingEndMark">
          —
         </span>
         For pregnant patients with persistent urethritis or cervicitis, we suggest high-dose
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         (1 g on day 1 followed by 500 mg on days 2 through 4). Although microbiologic cure rates with azithromycin-based regimens are low in the setting of a high prevalence of macrolide-resistant
         <em>
          M. genitalium
         </em>
         (which is the case in the United States and many other countries), associated clinical cure rates of 65 to 75 percent have been reported [
         <a href="#rid115">
          115
         </a>
         ].
        </p>
        <p>
         Other than the macrolides (and pristinamycin, which is not available in the United States), antibiotics with known activity against
         <em>
          M. genitalium
         </em>
         are generally avoided during pregnancy because of safety concerns.
        </p>
        <p class="headingAnchor" id="H261887751">
         <span class="h3">
          Management of moxifloxacin treatment failure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although uncommon, microbiologic or clinical failure following
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         poses a management challenge. The appropriate approach is unknown. Patients with persistent infection despite moxifloxacin therapy should be managed in consultation with an expert in sexually transmitted infections.
        </p>
        <p>
         Several approaches appear promising:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pristinamycin 1 g four times daily for 10 days (available mainly in European countries and in Australia). In small observational studies, this has been associated with microbiologic cure rates of 75 to 100 percent [
         <a href="#rid85">
          85,99,116,117
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9653" href="/z/d/drug information/9653.html" rel="external">
          Minocycline
         </a>
         100 mg twice daily for 14 days – In a series of 35 patients, this was associated with a microbiologic cure rate of 71 percent [
         <a href="#rid116">
          116
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nitroimidazoles – In a randomized trial evaluating the value of treating anaerobics in patients with PID,
         <em>
          M. genitalium
         </em>
         detection was unexpectedly less frequent among those who received
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         (4 versus 14 percent among those who did not) [
         <a href="#rid118">
          118
         </a>
         ]. Subsequently, an in vitro study showed that the nitroimidazoles had good antimicrobial activity against
         <em>
          M. genitalium
         </em>
         ;
         <a class="drug drug_general" data-topicid="10205" href="/z/d/drug information/10205.html" rel="external">
          tinidazole
         </a>
         was the most potent nitroimidazole tested
         <em>
         </em>
         [
         <a href="#rid119">
          119
         </a>
         ]
         <em>
          .
         </em>
         Tinidazole may be a possible treatment option, but clinical studies are needed to support its use.
        </p>
        <p>
        </p>
        <p>
         Two other antibiotics,
         <a class="drug drug_general" data-topicid="122343" href="/z/d/drug information/122343.html" rel="external">
          lefamulin
         </a>
         and
         <a class="drug drug_general" data-topicid="119253" href="/z/d/drug information/119253.html" rel="external">
          omadacycline
         </a>
         , have been reported to have good in vitro activity against
         <em>
          M. genitalium
         </em>
         [
         <a href="#rid120">
          120,121
         </a>
         ], but there are no published studies on their clinical efficacy.
        </p>
        <p class="headingAnchor" id="H8890831">
         <span class="h1">
          PARTNER MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most management guidelines recommend that sexual partners of laboratory-confirmed cases of
         <em>
          M. genitalium
         </em>
         should be tested for
         <em>
          M. genitalium
         </em>
         and treated, if positive. Although the incubation period of this pathogen remains undefined, case finding should target sexual partners in the past 60 days. If testing of sexual partners of index patients with confirmed
         <em>
          M. genitalium
         </em>
         is not possible, we favor empirically treating for
         <em>
          M. genitalium
         </em>
         , given the evidence of sexual transmission of this organism. (See
         <a class="local">
          'Microbiologic testing'
         </a>
         above.)
        </p>
        <p>
         Treatment for partners of patients with confirmed
         <em>
          M. genitalium
         </em>
         infection is the same as for patients. (See
         <a class="local">
          'Regimen selection for M. genitalium'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H2108694992">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111582.html" rel="external">
          "Society guideline links: Sexually transmitted infections"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11966339">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microbiology
         </strong>
         –
         <em>
          Mycoplasma genitalium
         </em>
         is a member of the Mycoplasmataceae family of bacteria. It is not visible on Gram stain because it lacks a cell wall, and culture of the organism is very difficult. (See
         <a class="local">
          'Microbiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevalence and risk factors
         </strong>
         – The prevalence of
         <em>
          M. genitalium
         </em>
         is approximately 1 percent in the general population but considerably higher among individuals at high risk for sexually transmitted infections (STIs). Risk factors for
         <em>
          M. genitalium
         </em>
         infection are similar to those associated with
         <em>
          Chlamydia trachomatis
         </em>
         infection and include young age and more than one recent sexual partner. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical syndromes
         </strong>
         –
         <em>
          M. genitalium
         </em>
         is an important cause of nongonococcal urethritis in males, cervicitis in females, and possibly pelvic inflammatory disease (PID) in females. It is uncertain whether it causes proctitis in men who have sex with men (MSM). There is no clear evidence that
         <em>
          M. genitalium
         </em>
         is associated with any human diseases outside the anogenital tract. (See
         <a class="local">
          'Associated clinical syndromes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The clinical manifestations of
         <em>
          M. genitalium
         </em>
         urogenital infection are similar to those caused by
         <em>
          C. trachomatis
         </em>
         infection in both males and females.
         <em>
          M. genitalium
         </em>
         urethritis is typically symptomatic, whereas females with cervicitis associated with
         <em>
          M. genitalium
         </em>
         are more frequently asymptomatic. (See
         <a class="local">
          'Associated clinical syndromes'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/83019.html" rel="external">
          "Clinical manifestations and diagnosis of
          <i>
           Chlamydia trachomatis
          </i>
          infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – –
         <em>
          M. genitalium
         </em>
         infection is diagnosed by detection of the organism using nucleic acid amplification tests (NAATs) on urogenital specimens, such as first-catch urine in males and a vaginal swab in females. We suggest testing symptomatic patients with urethritis, cervicitis, and PID for
         <em>
          M. genitalium
         </em>
         . We also suggest testing patients who have persistent symptoms following empiric syndromic therapy. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Approach to persistent symptoms after initial syndromic therapy
         </strong>
         – Empiric syndromic treatment of urethritis, cervicitis, and PID includes coverage of
         <em>
          C. trachomatis
         </em>
         , generally with multi-dose
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         or single-dose
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         . While these regimens are active to varying degrees against
         <em>
          M. genitalium
         </em>
         , they are not optimal, and clinical treatment failure is commonly associated with
         <em>
          M. genitalium
         </em>
         infection. For patients with persistent urethritis or cervicitis following initial therapy who were not tested for
         <em>
          M. genitalium
         </em>
         at initial presentation, we suggest empirically treating for
         <em>
          M. genitalium
         </em>
         in addition to testing for the organism (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). (See
         <a class="local">
          'Empiric syndromic therapy and M. genitalium'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Regimen selection for
         </strong>
         <strong>
          <em>
           M. genitalium
          </em>
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For empiric or directed therapy of
         <em>
          M. genitalium
         </em>
         in nonpregnant patients, we suggest
         <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">
          doxycycline
         </a>
         (100 mg twice daily for seven days) followed by
         <a class="drug drug_general" data-topicid="10311" href="/z/d/drug information/10311.html" rel="external">
          moxifloxacin
         </a>
         (400 mg orally daily for seven days) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). For patients who cannot use moxifloxacin, doxycycline followed by high-dose
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         for four days (1 g once followed by 500 mg daily the next three days) is a reasonable alternative. Both regimens have been associated with high microbiologic and clinical cure rates for macrolide-susceptible
         <em>
          M. genitalium
         </em>
         infection, but the increasing prevalence of macrolide resistance limits the microbiologic efficacy of azithromycin-based regimens. If resistance testing is available, those results can be used to choose between the two regimens. (See
         <a class="local">
          'Nonpregnant individuals'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For empiric or directed therapy of
         <em>
          M. genitalium
         </em>
         in pregnant patients, we suggest high-dose
         <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">
          azithromycin
         </a>
         treatment (1 g on day 1 followed by 500 mg daily on days 2 through 4) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Most other antibiotics with activity against
         <em>
          M. genitalium
         </em>
         are generally avoided in pregnancy. (See
         <a class="local">
          'Pregnant individuals'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1416370344">
         <span class="h1">
          ACKNOWLEDGMENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The editorial staff at UpToDate would like to acknowledge Victoria Mobley, MD, MPH, and Arlene C Seña, MD, MPH, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Tully JG, Taylor-Robinson D, Cole RM, Rose DL. A newly discovered mycoplasma in the human urogenital tract. Lancet 1981; 1:1288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manhart LE. Mycoplasma genitalium: An emergent sexually transmitted disease? Infect Dis Clin North Am 2013; 27:779.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Svenstrup HF, Jensen JS, Björnelius E, et al. Development of a quantitative real-time PCR assay for detection of Mycoplasma genitalium. J Clin Microbiol 2005; 43:3121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Himmelreich R, Plagens H, Hilbert H, et al. Comparative analysis of the genomes of the bacteria Mycoplasma pneumoniae and Mycoplasma genitalium. Nucleic Acids Res 1997; 25:701.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamasuna R, Osada Y, Jensen JS. Isolation of Mycoplasma genitalium from first-void urine specimens by coculture with Vero cells. J Clin Microbiol 2007; 45:847.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baseman JB, Cagle M, Korte JE, et al. Diagnostic assessment of Mycoplasma genitalium in culture-positive women. J Clin Microbiol 2004; 42:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Razin S, Yogev D, Naot Y. Molecular biology and pathogenicity of mycoplasmas. Microbiol Mol Biol Rev 1998; 62:1094.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen JS. Mycoplasma genitalium infections. Diagnosis, clinical aspects, and pathogenesis. Dan Med Bull 2006; 53:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor-Robinson D, Furr PM, Tully JG, et al. Animal models of Mycoplasma genitalium urogenital infection. Isr J Med Sci 1987; 23:561.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor-Robinson D, Jensen JS. Mycoplasma genitalium: from Chrysalis to multicolored butterfly. Clin Microbiol Rev 2011; 24:498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ross JD, Jensen JS. Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment. Sex Transm Infect 2006; 82:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McGowin CL, Annan RS, Quayle AJ, et al. Persistent Mycoplasma genitalium infection of human endocervical epithelial cells elicits chronic inflammatory cytokine secretion. Infect Immun 2012; 80:3842.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vandepitte J, Weiss HA, Kyakuwa N, et al. Natural history of Mycoplasma genitalium infection in a cohort of female sex workers in Kampala, Uganda. Sex Transm Dis 2013; 40:422.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cazanave C, Manhart LE, Bébéar C. Mycoplasma genitalium, an emerging sexually transmitted pathogen. Med Mal Infect 2012; 42:381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walker J, Fairley CK, Bradshaw CS, et al. Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women. Clin Infect Dis 2013; 56:1094.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Svenstrup HF, Dave SS, Carder C, et al. A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London. BMJ Open 2014; 4:e003947.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manhart LE, Holmes KK, Hughes JP, et al. Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. Am J Public Health 2007; 97:1118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           le Roux MC, Hoosen AA. Quantitative Real-Time Polymerase Chain Reaction for the Diagnosis of Mycoplasma genitalium Infection in South African Men With and Without Symptoms of Urethritis. Sex Transm Dis 2017; 44:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Munson E, Wenten D, Jhansale S, et al. Expansion of Comprehensive Screening of Male Sexually Transmitted Infection Clinic Attendees with Mycoplasma genitalium and Trichomonas vaginalis Molecular Assessment: a Retrospective Analysis. J Clin Microbiol 2017; 55:321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Getman D, Jiang A, O'Donnell M, Cohen S. Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States. J Clin Microbiol 2016; 54:2278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seña AC, Lee JY, Schwebke J, et al. A Silent Epidemic: The Prevalence, Incidence and Persistence of Mycoplasma genitalium Among Young, Asymptomatic High-Risk Women in the United States. Clin Infect Dis 2018; 67:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hancock EB, Manhart LE, Nelson SJ, et al. Comprehensive assessment of sociodemographic and behavioral risk factors for Mycoplasma genitalium infection in women. Sex Transm Dis 2010; 37:777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manhart LE, Critchlow CW, Holmes KK, et al. Mucopurulent cervicitis and Mycoplasma genitalium. J Infect Dis 2003; 187:650.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mobley VL, Hobbs MM, Lau K, et al. Mycoplasma genitalium infection in women attending a sexually transmitted infection clinic: diagnostic specimen type, coinfections, and predictors. Sex Transm Dis 2012; 39:706.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huppert JS, Mortensen JE, Reed JL, et al. Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women. Sex Transm Dis 2008; 35:250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tosh AK, Van Der Pol B, Fortenberry JD, et al. Mycoplasma genitalium among adolescent women and their partners. J Adolesc Health 2007; 40:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andersen B, Sokolowski I, Østergaard L, et al. Mycoplasma genitalium: prevalence and behavioural risk factors in the general population. Sex Transm Infect 2007; 83:237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wetmore CM, Manhart LE, Lowens MS, et al. Demographic, behavioral, and clinical characteristics of men with nongonococcal urethritis differ by etiology: a case-comparison study. Sex Transm Dis 2011; 38:180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oakeshott P, Aghaizu A, Hay P, et al. Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study. Clin Infect Dis 2010; 51:1160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vandepitte J, Muller E, Bukenya J, et al. Prevalence and correlates of Mycoplasma genitalium infection among female sex workers in Kampala, Uganda. J Infect Dis 2012; 205:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Falk L, Fredlund H, Jensen JS. Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis. Sex Transm Infect 2004; 80:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Falk L, Fredlund H, Jensen JS. Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sex Transm Infect 2005; 81:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One 2008; 3:e3618.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thurman AR, Musatovova O, Perdue S, et al. Mycoplasma genitalium symptoms, concordance and treatment in high-risk sexual dyads. Int J STD AIDS 2010; 21:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cina M, Baumann L, Egli-Gany D, et al. Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta-analysis. Sex Transm Infect 2019; 95:328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Musatovova O, Baseman JB. Analysis identifying common and distinct sequences among Texas clinical strains of Mycoplasma genitalium. J Clin Microbiol 2009; 47:1469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hjorth SV, Björnelius E, Lidbrink P, et al. Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. J Clin Microbiol 2006; 44:2078.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ma L, Taylor S, Jensen JS, et al. Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system. BMC Microbiol 2008; 8:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casin I, Vexiau-Robert D, De La Salmonière P, et al. High prevalence of Mycoplasma genitalium in the lower genitourinary tract of women attending a sexually transmitted disease clinic in Paris, France. Sex Transm Dis 2002; 29:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaydos C, Maldeis NE, Hardick A, et al. Mycoplasma genitalium compared to chlamydia, gonorrhoea and trichomonas as an aetiological agent of urethritis in men attending STD clinics. Sex Transm Infect 2009; 85:438.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mena L, Wang X, Mroczkowski TF, Martin DH. Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted diseases clinic in New Orleans. Clin Infect Dis 2002; 35:1167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor-Robinson D, Renton A, Jensen JS, et al. Association of Mycoplasma genitalium with acute non-gonococcal urethritis in Russian men: a comparison with gonococcal and chlamydial urethritis. Int J STD AIDS 2009; 20:234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnston LG, Paz-Bailey G, Morales-Miranda S, et al. High prevalence of Mycoplasma genitalium among female sex workers in Honduras: implications for the spread of HIV and other sexually transmitted infections. Int J STD AIDS 2012; 23:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Månsson F, Camara C, Biai A, et al. High prevalence of HIV-1, HIV-2 and other sexually transmitted infections among women attending two sexual health clinics in Bissau, Guinea-Bissau, West Africa. Int J STD AIDS 2010; 21:631.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen CR, Nosek M, Meier A, et al. Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya. Sex Transm Dis 2007; 34:274.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lusk MJ, Konecny P, Naing ZW, et al. Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population. Sex Transm Infect 2011; 87:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soni S, Alexander S, Verlander N, et al. The prevalence of urethral and rectal Mycoplasma genitalium and its associations in men who have sex with men attending a genitourinary medicine clinic. Sex Transm Infect 2010; 86:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mavedzenge SN, Van Der Pol B, Weiss HA, et al. The association between Mycoplasma genitalium and HIV-1 acquisition in African women. AIDS 2012; 26:617.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roxby AC, Yuhas K, Farquhar C, et al. Mycoplasma genitalium infection among HIV-infected pregnant African women and implications for mother-to-child transmission of HIV. AIDS 2019; 33:2211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vandepitte J, Weiss HA, Bukenya J, et al. Association between Mycoplasma genitalium infection and HIV acquisition among female sex workers in Uganda: evidence from a nested case-control study. Sex Transm Infect 2014; 90:545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Napierala Mavedzenge S, Müller EE, Lewis DA, et al. Mycoplasma genitalium is associated with increased genital HIV type 1 RNA in Zimbabwean women. J Infect Dis 2015; 211:1388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Das K, De la Garza G, Siwak EB, et al. Mycoplasma genitalium promotes epithelial crossing and peripheral blood mononuclear cell infection by HIV-1. Int J Infect Dis 2014; 23:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021; 70:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen JS, Orsum R, Dohn B, et al. Mycoplasma genitalium: a cause of male urethritis? Genitourin Med 1993; 69:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anagrius C, Loré B, Jensen JS. Mycoplasma genitalium: prevalence, clinical significance, and transmission. Sex Transm Infect 2005; 81:458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horner PJ, Taylor-Robinson D. Association of Mycoplasma genitalium with balanoposthitis in men with non-gonococcal urethritis. Sex Transm Infect 2011; 87:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen JS. Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases. J Eur Acad Dermatol Venereol 2004; 18:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manhart LE, Broad JM, Golden MR. Mycoplasma genitalium: should we treat and how? Clin Infect Dis 2011; 53 Suppl 3:S129.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mena LA, Mroczkowski TF, Nsuami M, Martin DH. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis 2009; 48:1649.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wikström A, Jensen JS. Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline. Sex Transm Infect 2006; 82:276.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Latimer RL, Read TRH, Vodstrcil LA, et al. Clinical Features and Therapeutic Response in Women Meeting Criteria for Presumptive Treatment for Pelvic Inflammatory Disease Associated With Mycoplasma genitalium. Sex Transm Dis 2019; 46:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lillis RA, Martin DH, Nsuami MJ. Mycoplasma genitalium Infections in Women Attending a Sexually Transmitted Disease Clinic in New Orleans. Clin Infect Dis 2019; 69:459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Korte JE, Baseman JB, Cagle MP, et al. Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium. Am J Reprod Immunol 2006; 55:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pépin J, Labbé AC, Khonde N, et al. Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers. Sex Transm Infect 2005; 81:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaydos C, Maldeis NE, Hardick A, et al. Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics. Sex Transm Dis 2009; 36:598.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Högdahl M, Kihlström E. Leucocyte esterase testing of first-voided urine and urethral and cervical smears to identify Mycoplasma genitalium-infected men and women. Int J STD AIDS 2007; 18:835.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moi H, Reinton N, Moghaddam A. Mycoplasma genitalium in women with lower genital tract inflammation. Sex Transm Infect 2009; 85:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lis R, Rowhani-Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis 2015; 61:418.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haggerty CL, Totten PA, Astete SG, Ness RB. Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. Infect Dis Obstet Gynecol 2006; 2006:30184.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen CR, Manhart LE, Bukusi EA, et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002; 359:765.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bjartling C, Osser S, Persson K. The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy. BJOG 2010; 117:361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haggerty CL, Totten PA, Astete SG, et al. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect 2008; 84:338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Short VL, Totten PA, Ness RB, et al. Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. Clin Infect Dis 2009; 48:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis J, Horner PJ, White PJ. Incidence of Pelvic Inflammatory Disease Associated With Mycoplasma genitalium Infection: Evidence Synthesis of Cohort Study Data. Clin Infect Dis 2020; 71:2719.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ong JJ, Aung E, Read TRH, et al. Clinical Characteristics of Anorectal Mycoplasma genitalium Infection and Microbial Cure in Men Who Have Sex With Men. Sex Transm Dis 2018; 45:522.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Read TRH, Murray GL, Danielewski JA, et al. Symptoms, Sites, and Significance of Mycoplasma genitalium in Men Who Have Sex with Men. Emerg Infect Dis 2019; 25:719.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramakrishnan G, Kronig I, Gaïa N, et al. Mycoplasma genitalium Endocarditis in Prosthetic Aortic Valve. Emerg Infect Dis 2023; 29:2164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen JS, Björnelius E, Dohn B, Lidbrink P. Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic. Sex Transm Dis 2004; 31:499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shipitsyna E, Zolotoverkhaya E, Dohn B, et al. First evaluation of polymerase chain reaction assays used for diagnosis of Mycoplasma genitalium in Russia. J Eur Acad Dermatol Venereol 2009; 23:1164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wroblewski JK, Manhart LE, Dickey KA, et al. Comparison of transcription-mediated amplification and PCR assay results for various genital specimen types for detection of Mycoplasma genitalium. J Clin Microbiol 2006; 44:3306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lillis RA, Nsuami MJ, Myers L, Martin DH. Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women. J Clin Microbiol 2011; 49:1990.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ross JD, Brown L, Saunders P, Alexander S. Mycoplasma genitalium in asymptomatic patients: implications for screening. Sex Transm Infect 2009; 85:436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson KA, Sankaran M, Kohn RP, et al. Testing for Mycoplasma genitalium and Using Doxycycline as First-Line Therapy at Initial Presentations for Non-Gonococcal Urethritis (NGU) Correlate With Reductions in Persistent NGU. Clin Infect Dis 2023; 76:1674.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soni S, Horner P, Rayment M, et al. British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018). Int J STD AIDS 2019; 30:938.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen JS, Cusini M, Gomberg M, Moi H. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol 2016; 30:1650.
          </a>
         </li>
         <li class="breakAll">
          Mycoplasma genitalium. Australian STI Management Guidelines for Use in Primany Care. http://www.sti.guidelines.org.au/sexually-transmissible-infections/mycoplasma-genitalium (Accessed on August 10, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Golden MR, Workowski KA, Bolan G. Developing a Public Health Response to Mycoplasma genitalium. J Infect Dis 2017; 216:S420.
          </a>
         </li>
         <li class="breakAll">
          FDA. Nucleic Acid Based Tests. https://www.fda.gov/medical-devices/in-vitro-diagnostics/nucleic-acid-based-tests#microbial (Accessed on October 18, 2023).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Le Roy C, Pereyre S, Hénin N, Bébéar C. French Prospective Clinical Evaluation of the Aptima Mycoplasma genitalium CE-IVD Assay and Macrolide Resistance Detection Using Three Distinct Assays. J Clin Microbiol 2017; 55:3194.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaydos CA. Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment. J Infect Dis 2017; 216:S406.
          </a>
         </li>
         <li class="breakAll">
          Aptima Mycoplasma genitalium assay package insert. https://www.hologic.com/sites/default/files/2019-07/AW-17946_002_01.pdf (Accessed on September 11, 2019).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herrmann B, Malm K. Comparison between Abbott m2000 RealTime and Alinity m STI systems for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium. Eur J Clin Microbiol Infect Dis 2021; 40:2217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Der Pol B, Waites KB, Xiao L, et al. Mycoplasma genitalium Detection in Urogenital Specimens from Symptomatic and Asymptomatic Men and Women by Use of the cobas TV/MG Test. J Clin Microbiol 2020; 58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel MA, Nyirjesy P. Role of Mycoplasma and ureaplasma species in female lower genital tract infections. Curr Infect Dis Rep 2010; 12:417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shipitsyna E, Savicheva A, Solokovskiy E, et al. Guidelines for the laboratory diagnosis of mycoplasma genitalium infections in East European countries. Acta Derm Venereol 2010; 90:461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waites KB, Xiao L, Paralanov V, et al. Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology. J Mol Diagn 2012; 14:437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Machalek DA, Tao Y, Shilling H, et al. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis. Lancet Infect Dis 2020; 20:1302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jensen JS, Bradshaw CS, Tabrizi SN, et al. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008; 47:1546.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bissessor M, Tabrizi SN, Twin J, et al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin Infect Dis 2015; 60:1228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pond MJ, Nori AV, Witney AA, et al. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. Clin Infect Dis 2014; 58:631.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Touati A, Peuchant O, Jensen JS, et al. Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis. J Clin Microbiol 2014; 52:1549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dionne-Odom J, Geisler WM, Aaron KJ, et al. High Prevalence of Multidrug-Resistant Mycoplasma genitalium in Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in Alabama. Clin Infect Dis 2018; 66:796.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xiao L, Waites KB, Van Der Pol B, et al. Mycoplasma genitalium Infections With Macrolide and Fluoroquinolone Resistance-Associated Mutations in Heterosexual African American Couples in Alabama. Sex Transm Dis 2019; 46:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradshaw CS, Jensen JS, Waites KB. New Horizons in Mycoplasma genitalium Treatment. J Infect Dis 2017; 216:S412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Y, Le WJ, Li S, et al. Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection. Int J STD AIDS 2017; :956462416688562.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Couldwell DL, Tagg KA, Jeoffreys NJ, Gilbert GL. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Int J STD AIDS 2013; 24:822.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murray GL, Bradshaw CS, Bissessor M, et al. Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium. Emerg Infect Dis 2017; 23:809.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murray GL, Bodiyabadu K, Danielewski J, et al. Moxifloxacin and Sitafloxacin Treatment Failure in Mycoplasma genitalium Infection: Association with parC Mutation G248T (S83I) and Concurrent gyrA Mutations. J Infect Dis 2020; 221:1017.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Unemo M, Jensen JS. Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium. Nat Rev Urol 2017; 14:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Read TRH, Fairley CK, Murray GL, et al. Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation. Clin Infect Dis 2019; 68:554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lau A, Bradshaw CS, Lewis D, et al. The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis. Clin Infect Dis 2015; 61:1389.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Romano SS, Jensen JS, Lowens MS, et al. Long Duration of Asymptomatic Mycoplasma genitalium Infection After Syndromic Treatment for Nongonococcal Urethritis. Clin Infect Dis 2019; 69:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jernberg E, Moghaddam A, Moi H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 2008; 19:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Durukan D, Read TRH, Murray G, et al. Resistance-Guided Antimicrobial Therapy Using Doxycycline-Moxifloxacin and Doxycycline-2.5 g Azithromycin for the Treatment of Mycoplasma genitalium Infection: Efficacy and Tolerability. Clin Infect Dis 2020; 71:1461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bachmann LH, Kirkcaldy RD, Geisler WM, et al. Prevalence of Mycoplasma genitalium Infection, Antimicrobial Resistance Mutations, and Symptom Resolution Following Treatment of Urethritis. Clin Infect Dis 2020; 71:e624.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doyle M, Vodstrcil LA, Plummer EL, et al. Nonquinolone Options for the Treatment of Mycoplasma genitalium in the Era of Increased Resistance. Open Forum Infect Dis 2020; 7:ofaa291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Read TRH, Jensen JS, Fairley CK, et al. Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection. Emerg Infect Dis 2018; 24:328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiesenfeld HC, Meyn LA, Darville T, et al. A Randomized Controlled Trial of Ceftriaxone and Doxycycline, With or Without Metronidazole, for the Treatment of Acute Pelvic Inflammatory Disease. Clin Infect Dis 2021; 72:1181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wood GE, Kim CM, Aguila LKT, Cichewicz RH. In Vitro Susceptibility and Resistance of Mycoplasma genitalium to Nitroimidazoles. Antimicrob Agents Chemother 2023; 67:e0000623.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paukner S, Gruss A, Jensen JS. In Vitro Activity of Lefamulin against Sexually Transmitted Bacterial Pathogens. Antimicrob Agents Chemother 2018; 62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waites KB, Crabb DM, Atkinson TP, et al. Omadacycline Is Highly Active In Vitro against Mycoplasma genitalium. Microbiol Spectr 2022; 10:e0365422.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 83202 Version 36.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6112607" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : A newly discovered mycoplasma in the human urogenital tract.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24275270" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Mycoplasma genitalium: An emergent sexually transmitted disease?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16000423" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Development of a quantitative real-time PCR assay for detection of Mycoplasma genitalium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9016618" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Comparative analysis of the genomes of the bacteria Mycoplasma pneumoniae and Mycoplasma genitalium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17251394" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Isolation of Mycoplasma genitalium from first-void urine specimens by coculture with Vero cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14715754" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Diagnostic assessment of Mycoplasma genitalium in culture-positive women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9841667" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Molecular biology and pathogenicity of mycoplasmas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16542629" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Mycoplasma genitalium infections. Diagnosis, clinical aspects, and pathogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3667225" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Animal models of Mycoplasma genitalium urogenital infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21734246" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Mycoplasma genitalium: from Chrysalis to multicolored butterfly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16877571" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22907815" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Persistent Mycoplasma genitalium infection of human endocervical epithelial cells elicits chronic inflammatory cytokine secretion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23588134" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Natural history of Mycoplasma genitalium infection in a cohort of female sex workers in Kampala, Uganda.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22975074" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Mycoplasma genitalium, an emerging sexually transmitted pathogen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23300236" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Mycoplasma genitalium incidence, organism load, and treatment failure in a cohort of young Australian women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24503298" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17463380" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27898565" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Quantitative Real-Time Polymerase Chain Reaction for the Diagnosis of Mycoplasma genitalium Infection in South African Men With and Without Symptoms of Urethritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27629896" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Expansion of Comprehensive Screening of Male Sexually Transmitted Infection Clinic Attendees with Mycoplasma genitalium and Trichomonas vaginalis Molecular Assessment: a Retrospective Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27307460" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29342269" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : A Silent Epidemic: The Prevalence, Incidence and Persistence of Mycoplasma genitalium Among Young, Asymptomatic High-Risk Women in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20679963" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Comprehensive assessment of sociodemographic and behavioral risk factors for Mycoplasma genitalium infection in women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12599082" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Mucopurulent cervicitis and Mycoplasma genitalium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22902666" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Mycoplasma genitalium infection in women attending a sexually transmitted infection clinic: diagnostic specimen type, coinfections, and predictors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18490867" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17448398" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Mycoplasma genitalium among adolescent women and their partners.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17090566" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Mycoplasma genitalium: prevalence and behavioural risk factors in the general population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21285914" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Demographic, behavioral, and clinical characteristics of men with nongonococcal urethritis differ by etiology: a case-comparison study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20942656" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22102734" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Prevalence and correlates of Mycoplasma genitalium infection among female sex workers in Kampala, Uganda.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15295128" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15681728" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18978939" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Persistence of Mycoplasma genitalium following azithromycin therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20215621" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Mycoplasma genitalium symptoms, concordance and treatment in high-risk sexual dyads.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31055469" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19261784" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Analysis identifying common and distinct sequences among Texas clinical strains of Mycoplasma genitalium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16757601" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Sequence-based typing of Mycoplasma genitalium reveals sexual transmission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18664269" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12035026" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : High prevalence of Mycoplasma genitalium in the lower genitourinary tract of women attending a sexually transmitted disease clinic in Paris, France.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19383597" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Mycoplasma genitalium compared to chlamydia, gonorrhoea and trichomonas as an aetiological agent of urethritis in men attending STD clinics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12410476" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Mycoplasma genitalium infections in asymptomatic men and men with urethritis attending a sexually transmitted diseases clinic in New Orleans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19304966" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Association of Mycoplasma genitalium with acute non-gonococcal urethritis in Russian men: a comparison with gonococcal and chlamydial urethritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22362680" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : High prevalence of Mycoplasma genitalium among female sex workers in Honduras: implications for the spread of HIV and other sexually transmitted infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21097735" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : High prevalence of HIV-1, HIV-2 and other sexually transmitted infections among women attending two sexual health clinics in Bissau, Guinea-Bissau, West Africa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16940898" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21071566" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Mycoplasma genitalium is associated with cervicitis and HIV infection in an urban Australian STI clinic population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19843536" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : The prevalence of urethral and rectal Mycoplasma genitalium and its associations in men who have sex with men attending a genitourinary medicine clinic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22210630" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : The association between Mycoplasma genitalium and HIV-1 acquisition in African women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31385863" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Mycoplasma genitalium infection among HIV-infected pregnant African women and implications for mother-to-child transmission of HIV.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24687129" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Association between Mycoplasma genitalium infection and HIV acquisition among female sex workers in Uganda: evidence from a nested case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25404521" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Mycoplasma genitalium is associated with increased genital HIV type 1 RNA in Zimbabwean women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24661929" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Mycoplasma genitalium promotes epithelial crossing and peripheral blood mononuclear cell infection by HIV-1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34292926" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Sexually Transmitted Infections Treatment Guidelines, 2021.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7721285" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Mycoplasma genitalium: a cause of male urethritis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16326846" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Mycoplasma genitalium: prevalence, clinical significance, and transmission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20852310" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Association of Mycoplasma genitalium with balanoposthitis in men with non-gonococcal urethritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14678525" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22080266" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Mycoplasma genitalium: should we treat and how?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19438399" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16877573" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30640861" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Clinical Features and Therapeutic Response in Women Meeting Criteria for Presumptive Treatment for Pelvic Inflammatory Disease Associated With Mycoplasma genitalium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30351348" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Mycoplasma genitalium Infections in Women Attending a Sexually Transmitted Disease Clinic in New Orleans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16533338" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15681727" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19704398" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18073017" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Leucocyte esterase testing of first-voided urine and urethral and cervical smears to identify Mycoplasma genitalium-infected men and women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18842689" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Mycoplasma genitalium in women with lower genital tract inflammation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25900174" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17485798" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11888591" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Association between Mycoplasma genitalium and acute endometritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20015303" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18445635" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19025498" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32701123" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Incidence of Pelvic Inflammatory Disease Associated With Mycoplasma genitalium Infection: Evidence Synthesis of Cohort Study Data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29465653" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Clinical Characteristics of Anorectal Mycoplasma genitalium Infection and Microbial Cure in Men Who Have Sex With Men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30882306" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Symptoms, Sites, and Significance of Mycoplasma genitalium in Men Who Have Sex with Men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37735787" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Mycoplasma genitalium Endocarditis in Prosthetic Aortic Valve.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15273584" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19453801" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : First evaluation of polymerase chain reaction assays used for diagnosis of Mycoplasma genitalium in Russia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16954265" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Comparison of transcription-mediated amplification and PCR assay results for various genital specimen types for detection of Mycoplasma genitalium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21411587" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Utility of urine, vaginal, cervical, and rectal specimens for detection of Mycoplasma genitalium in women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19587392" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Mycoplasma genitalium in asymptomatic patients: implications for screening.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36575605" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Testing for Mycoplasma genitalium and Using Doxycycline as First-Line Therapy at Initial Presentations for Non-Gonococcal Urethritis (NGU) Correlate With Reductions in Persistent NGU.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31280688" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27505296" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : 2016 European guideline on Mycoplasma genitalium infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27505296" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : 2016 European guideline on Mycoplasma genitalium infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28838079" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Developing a Public Health Response to Mycoplasma genitalium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28838079" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Developing a Public Health Response to Mycoplasma genitalium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28794183" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : French Prospective Clinical Evaluation of the Aptima Mycoplasma genitalium CE-IVD Assay and Macrolide Resistance Detection Using Three Distinct Assays.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28838072" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28838072" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Mycoplasma genitalium: Accurate Diagnosis Is Necessary for Adequate Treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33723736" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Comparison between Abbott m2000 RealTime and Alinity m STI systems for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32213558" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Mycoplasma genitalium Detection in Urogenital Specimens from Symptomatic and Asymptomatic Men and Women by Use of the cobas TV/MG Test.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21308549" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Role of Mycoplasma and ureaplasma species in female lower genital tract infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20814619" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Guidelines for the laboratory diagnosis of mycoplasma genitalium infections in East European countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22819362" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Molecular methods for the detection of Mycoplasma and ureaplasma infections in humans: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32622378" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18990060" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25537875" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24280088" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24574291" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Direct detection of macrolide resistance in Mycoplasma genitalium isolates from clinical specimens from France by use of real-time PCR and melting curve analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29028993" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : High Prevalence of Multidrug-Resistant Mycoplasma genitalium in Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in Alabama.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29979336" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Mycoplasma genitalium Infections With Macrolide and Fluoroquinolone Resistance-Associated Mutations in Heterosexual African American Couples in Alabama.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28838073" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : New Horizons in Mycoplasma genitalium Treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28118803" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24052013" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28418319" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32031634" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Moxifloxacin and Sitafloxacin Treatment Failure in Mycoplasma genitalium Infection: Association with parC Mutation G248T (S83I) and Concurrent gyrA Mutations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28072403" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29873691" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26240201" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30281079" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Long Duration of Asymptomatic Mycoplasma genitalium Infection After Syndromic Treatment for Nongonococcal Urethritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18824619" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31629365" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Resistance-Guided Antimicrobial Therapy Using Doxycycline-Moxifloxacin and Doxycycline-2.5 g Azithromycin for the Treatment of Mycoplasma genitalium Infection: Efficacy and Tolerability.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32185385" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Prevalence of Mycoplasma genitalium Infection, Antimicrobial Resistance Mutations, and Symptom Resolution Following Treatment of Urethritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32782911" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Nonquinolone Options for the Treatment of Mycoplasma genitalium in the Era of Increased Resistance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29350154" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32052831" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : A Randomized Controlled Trial of Ceftriaxone and Doxycycline, With or Without Metronidazole, for the Treatment of Acute Pelvic Inflammatory Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37070857" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : In Vitro Susceptibility and Resistance of Mycoplasma genitalium to Nitroimidazoles.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29530863" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : In Vitro Activity of Lefamulin against Sexually Transmitted Bacterial Pathogens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36314935" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Omadacycline Is Highly Active In Vitro against Mycoplasma genitalium.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
